Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17419ExperimentalSmall molecule
S-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against B-cell neoplasias.
- Formula / weight
- C13H11N3O4 · 273.2441 g/mol (avg)
- Also known as
- S-3-[3-amino-phthalimido]-glutarimide
- Code names
- S-3APG
Resolves to
Structure
InChIKey
UVSMNLNDYGZFPF-UHFFFAOYSA-NSMILESNC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1What you can answer from here — as of September 13, 2026
Which companies are running trials of S-3APG, in which indications and phases, and which of those programs are still active?